Literature DB >> 22207756

Productive recognition of factor IX by factor XIa exosites requires disulfide linkage between heavy and light chains of factor XIa.

Mariola M Marcinkiewicz1, Dipali Sinha, Peter N Walsh.   

Abstract

In the intrinsic pathway of blood coagulation factor XIa (FXIa) activates factor IX (FIX) by cleaving the zymogen at Arg(145)-Ala(146) and Arg(180)-Val(181) bonds releasing an 11-kDa activation peptide. FXIa and its isolated light chain (FXIa-LC) cleave S-2366 at comparable rates, but FXIa-LC is a very poor activator of FIX, possibly because FIX undergoes allosteric modification on binding to an exosite on the heavy chain of FXIa (FXIa-HC) required for optimal cleavage rates of the two scissile bonds of FIX. However preincubation of FIX with a saturating concentration of isolated FXIa-HC did not result in any potentiation in the rate of FIX cleavage by FXIa-LC. Furthermore, if FIX binding via the heavy chain exosite of FXIa determines the affinity of the enzyme-substrate interaction, then the isolated FXIa-HC should inhibit the rate of FIX activation by depleting the substrate. However, whereas FXIa/S557A inhibited FIX activation of by FXIa, FXIa-HC did not. Therefore, we examined FIX binding to FXIa/S557A, FXIa-HC, FXIa-LC, FXIa/C362S/C482S, and FXIa/S557A/C362S/C482S. The heavy and light chains are disulfide-linked in FXIa/S557A but not in FXIa/C362S/C482S and FXIa/S557A/C362S/C482S. In an ELISA assay only FXI/S557A ligated FIX with high affinity. Partial reduction of FXIa/S557A to produce heavy and light chains resulted in decreased FIX binding, and this function was regained upon reformation of the disulfide linkage between the heavy and the light chains. We therefore conclude that substrate recognition by the FXIa exosite(s) requires disulfide-linked heavy and light chains.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22207756      PMCID: PMC3307291          DOI: 10.1074/jbc.M111.291989

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

Review 1.  Regulation of coagulation by a multivalent Kunitz-type inhibitor.

Authors:  G J Broze; T J Girard; W F Novotny
Journal:  Biochemistry       Date:  1990-08-21       Impact factor: 3.162

Review 2.  The coagulation cascade: initiation, maintenance, and regulation.

Authors:  E W Davie; K Fujikawa; W Kisiel
Journal:  Biochemistry       Date:  1991-10-29       Impact factor: 3.162

3.  Factor XI homodimer structure is essential for normal proteolytic activation by factor XIIa, thrombin, and factor XIa.

Authors:  Wenman Wu; Dipali Sinha; Sergei Shikov; Calvin K Yip; Thomas Walz; Paul C Billings; James D Lear; Peter N Walsh
Journal:  J Biol Chem       Date:  2008-04-25       Impact factor: 5.157

4.  Location of the disulfide bonds in human coagulation factor XI: the presence of tandem apple domains.

Authors:  B A McMullen; K Fujikawa; E W Davie
Journal:  Biochemistry       Date:  1991-02-26       Impact factor: 3.162

5.  Role of calcium ions and the heavy chain of factor XIa in the activation of human coagulation factor IX.

Authors:  D Sinha; F S Seaman; P N Walsh
Journal:  Biochemistry       Date:  1987-06-30       Impact factor: 3.162

6.  Functional characterization of human blood coagulation factor XIa using hybridoma antibodies.

Authors:  D Sinha; A Koshy; F S Seaman; P N Walsh
Journal:  J Biol Chem       Date:  1985-09-05       Impact factor: 5.157

7.  Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces.

Authors:  K Naito; K Fujikawa
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

8.  Development of a sensitive and rapid chromogenic factor IX assay for clinical use.

Authors:  R Wagenvoord; H Hendrix; T Tran; H C Hemker
Journal:  Haemostasis       Date:  1990

9.  Factor XI activation in a revised model of blood coagulation.

Authors:  D Gailani; G J Broze
Journal:  Science       Date:  1991-08-23       Impact factor: 47.728

10.  The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action.

Authors:  G J Broze; L A Warren; W F Novotny; D A Higuchi; J J Girard; J P Miletich
Journal:  Blood       Date:  1988-02       Impact factor: 22.113

View more
  1 in total

1.  A sequential mechanism for exosite-mediated factor IX activation by factor XIa.

Authors:  Yipeng Geng; Ingrid M Verhamme; Amanda Messer; Mao-fu Sun; Stephen B Smith; S Paul Bajaj; David Gailani
Journal:  J Biol Chem       Date:  2012-09-07       Impact factor: 5.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.